Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre

Inflammatory Bowel Disease

Management of COVID-19 Pandemic in Spanish Inflammatory Bowel Disease Units: Results From a National Survey

Inflamm Bowel Dis.

Martin Arranz E, Suarez Ferrer C, García Ramírez L, Rueda García JL, Sánchez-Azofra M, Poza Cordón J, Noci J, Zabana Y, Barreiro-de Acosta M, Martín-Arranz MD

doi: 10.1093/ibd/izaa142.

Inflammatory Bowel Disease

Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period

Lancet Gastroenterol Hepatol.

Iacucci M, Cannatelli R, Labarile N, Mao R, Panaccione R, Danese S, Kochhar GS, Ghosh S, Shen B

doi: 10.1016/S2468-1253(20)30119-9.

COMMENTED

Inflammatory Bowel Disease

Corticosteroids, but not TNF Antagonists, are Associated with Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results from an International Registry

★ 3 Recommended and commented by PD Dr Luc Biedermann, Faculty Member

★ 3 Recommended by Prof. Dr Stephan Vavricka, Faculty Member

Gastroenterology.

Brenner EJ, Ungaro RC, Gearry RB, Kaplan GG, Kissous-Hunt M, Lewis JD, Ng SC, Rahier JF, Reinisch W, Ruemmele FM, Steinwurz F, Underwood FE, Zhang X, Colombel JF, Kappelman MD

doi: 10.1053/j.gastro.2020.05.032.

Inflammatory Bowel Disease

Clinical trials for inflammatory bowel disease: a global guidance during COVID-19 pandemic

J Crohns Colitis.

Reinisch W, Danese S, Peyrin-Biroulet L, Loftus EV

doi: 10.1093/ecco-jcc/jjaa119.

Inflammatory Bowel Disease

Incidence and patterns of COVID-19 among inflammatory bowel disease patients from the Nancy and Milan cohorts

Clin Gastroenterol Hepatol.

Allocca M, Fiorino G, Zallot C, Furfaro F, Gilardi D, Radice S, Danese S, Peyrin-Biroulet L

doi: 10.1016/j.cgh.2020.04.071.

Inflammatory Bowel Disease

High Patient Activation Is Associated With Remission in Patients With Inflammatory Bowel Disease

Inflamm Bowel Dis.

Barnes EL, Long MD, Kappelman MD, Martin CF, Sandler RS

doi: 10.1093/ibd/izy378.

Inflammatory Bowel Disease

Systematic Review with Meta-analysis: The Impact of Co-occurring Immune-mediated Inflammatory Diseases on the Disease Course of Inflammatory Bowel Diseases

Inflamm Bowel Dis.

Attauabi M, Zhao M, Bendtsen F, Burisch J

doi: 10.1093/ibd/izaa167.

Inflammatory Bowel Disease

Illness Perception in Inflammatory Bowel Disease Patients is Different Between Patients With Active Disease or in Remission: A Prospective Cohort Study

doi: 10.1093/ecco-jcc/jjy183.

Inflammatory Bowel Disease

Risk and outcomes of coronavirus disease (COVID-19) in patients with inflammatory bowel disease: a systematic review and meta-analysis

United European Gastroenterol J

Singh AK, Jena A, Kumar-M P, Sharma V, Sebastian S

doi: 10.1177/2050640620972602

Related content

Management of COVID-19 Pandemic in Spanish Inflammatory Bowel Disease Units: Results From a National Survey

Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period

Corticosteroids, but not TNF Antagonists, are Associated with Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results from an International Registry

Clinical trials for inflammatory bowel disease: a global guidance during COVID-19 pandemic

Incidence and patterns of COVID-19 among inflammatory bowel disease patients from the Nancy and Milan cohorts

High Patient Activation Is Associated With Remission in Patients With Inflammatory Bowel Disease

Systematic Review with Meta-analysis: The Impact of Co-occurring Immune-mediated Inflammatory Diseases on the Disease Course of Inflammatory Bowel Diseases

Illness Perception in Inflammatory Bowel Disease Patients is Different Between Patients With Active Disease or in Remission: A Prospective Cohort Study

Risk and outcomes of coronavirus disease (COVID-19) in patients with inflammatory bowel disease: a systematic review and meta-analysis